BioAge Labs (BIOA) Income from Continuing Operations (2023 - 2026)

BioAge Labs has disclosed Income from Continuing Operations across 4 years of filings, most recently posting 22146000.0 for Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 22146000.0, down 70.52% year-over-year; the trailing twelve-month figure through Mar 2026 was 89550000.0 (down 25.8% YoY), and the FY2025 annual result was 80391000.0, down 13.34% from the prior year.
• Income from Continuing Operations came in at 22146000.0 for Q1 2026 at BioAge Labs, up from 25723000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 11791000.0 in Q3 2023 to a low of 25723000.0 in Q4 2025.
• The 4-year median for Income from Continuing Operations is 20129000.0 (2025), against an average of 18276000.0.
• Across the five-year window, Income from Continuing Operations plunged 95.92% in 2024 and advanced 12.87% in 2025, its largest moves.
• BioAge Labs' Income from Continuing Operations stood at 15776000.0 in 2023, then sank by 36.83% to 21586000.0 in 2024, then decreased by 19.17% to 25723000.0 in 2025, then rose by 13.91% to 22146000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 22146000.0 (Q1 2026), 25723000.0 (Q4 2025), and 20129000.0 (Q3 2025), per Business Quant data.